CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Explore how CDK4/6 inhibitors improve overall survival in HR+/HER2- advanced breast cancer patients with Dr. Anju Malhotra.

Speakers : Dr. Anju Malhotra

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

Explore advanced urothelial carcinoma treatment strategies with Dr. Nagender Sharma. Discover immunotherapy, targeted therapies, and personalized approaches in this expert-led oncology discussion.

Speakers : Dr Nagendra Sharma

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

xplore MRD-guided therapies in adult R/R B-ALL, with insights on CAR-T, blinatumomab, and personalized strategies for achieving long-term remission.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Discover groundbreaking treatments offering new hope for adults with relapsed B-cell ALL. Explore the latest advances, therapies, and strategies transforming outcomes in this challenging leukemia.

Speakers : Dr Riyaz Ahmed ,Dr Isha Kaul ,Dr Nitin Gupta

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Learn about early relapse in B-cell ALL, including relapse rates within the first year, key risk factors, and the most common sites like bone marrow and CNS.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Explore optimal first-salvage therapies for adult R/R B-Cell ALL with high disease burden, advancing remission and personalized treatment.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Exploring novel therapies and redefining long-term survival outcomes in adult relapsed/refractory B-cell ALL through precision and immunotherapy.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Explore the hospitalization burden, healthcare impact, and resource demands in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Explore the incidence of lung cancer and key insights into ALK-rearranged NSCLC with Dr. Vamshi Krishna M. Learn about diagnosis, targeted therapies, and advancements in treatment.

Speakers : Dr. Vamsi Krishna M


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot